Guardian Pharmacy Services, Inc. (GRDN) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
GRDN EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
GRDN Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 19.5% | 6.1% | 3.4% |
| 2024 | 19.9% | -5.1% | -7.1% |
| 2023 | 19.9% | 3.9% | 2.3% |
| 2022 | 20.4% | 5.7% | 3.9% |
| 2021 | 20.4% | 3.8% | 2.1% |
Download Data
Export GRDN earnings history in CSV or JSON format
Free sign-in required to download data
Guardian Pharmacy Services, Inc. (GRDN) Earnings Overview
As of May 8, 2026, Guardian Pharmacy Services, Inc. (GRDN) reported trailing twelve-month net income of $53M, reflecting +144.1% year-over-year growth. The company earned $0.83 per diluted share over the past four quarters, with a net profit margin of 3.4%.
Looking at the long-term picture, GRDN's 5-year EPS compound annual growth rate (CAGR) stands at +18.8%, indicating exceptional earnings growth. The company achieved its highest annual net income of $49M in fiscal 2025, representing a new all-time high.
Guardian Pharmacy Services, Inc. maintains positive profitability with a gross margin of 19.5%, operating margin of 6.1%, and net margin of 3.4%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including OMCL ($20M net income, 0.2% margin), PINC (-$24M net income, 2.0% margin), CVS ($2.93B net income, 0.4% margin), GRDN has outperformed on profitability metrics. Compare GRDN vs OMCL →
GRDN Earnings vs Peers
Earnings metrics vs comparable public companies
GRDN Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $49M | +156.4% | $89M | $0.78 | 3.4% | 6.1% |
| 2024 | -$87M | -465.2% | -$63M | $-1.77 | -7.1% | -5.1% |
| 2023 | $24M | -32.5% | $41M | $0.39 | 2.3% | 3.9% |
| 2022 | $35M | +117.1% | $52M | $0.58 | 3.9% | 5.7% |
| 2021 | $16M | -18.2% | $30M | $0.27 | 2.1% | 3.8% |
| 2020 | $20M | -8.3% | $32M | $0.33 | 2.7% | 4.4% |
| 2019 | $22M | +48.1% | $34M | $0.36 | 3.1% | 4.9% |
| 2018 | $15M | - | $26M | $0.24 | 2.4% | 4.3% |
See GRDN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GRDN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GRDN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGRDN — Frequently Asked Questions
Quick answers to the most common questions about buying GRDN stock.
Is GRDN growing earnings?
GRDN EPS is $0.83, with earnings growth accelerating to +144.1%. This exceeds the 5-year CAGR of +18.8%. TTM net income reached $53M.
What are GRDN's profit margins?
Guardian Pharmacy Services, Inc. net margin is +3.4%, with operating margin at +6.1%. Below-average margins reflect competitive or cost pressures.
How consistent are GRDN's earnings?
GRDN earnings data spans 2018-2025. The accelerating earnings trend is +144.1% YoY. Historical data enables comparison across business cycles.